3 Healthcare Stocks We're Skeptical Of [Yahoo! Finance]
LeMaitre Vascular, Inc. (LMAT)
Last lemaitre vascular, inc. earnings: 4/30 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
lemaitre.gcs-web.com/investor-relations
Company Research
Source: Yahoo! Finance
Players catalyzing medical advancements have benefited from elevated demand, which has supported the industry's returns lately - over the past six months, healthcare stocks have gained 3.8%, nearly mirrorring the S&P 500. Although these businesses have produced results, only a handful will thrive over the long term as the influx of venture capital has ushered in a new wave of competition. On that note, here are three healthcare stocks best left ignored. Moderna (MRNA) Market Cap: $21.09 billion Rising to global prominence during the COVID-19 pandemic with one of the first effective vaccines, Moderna (NASDAQ:MRNA) develops messenger RNA (mRNA) medicines that direct the body's cells to produce proteins with therapeutic or preventive benefits for various diseases. Why Do We Avoid MRNA? Annual sales declines of 46.7% for the past two years show its products and services struggled to connect with the market during this cycle Incremental sales over the last five years were muc
Show less
Read more
Impact Snapshot
Event Time:
LMAT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LMAT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LMAT alerts
High impacting LeMaitre Vascular, Inc. news events
Weekly update
A roundup of the hottest topics
LMAT
News
- LeMaitre Vascular (LMAT) was upgraded by <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a> from "hold (c+)" to "buy (b-)".MarketBeat
- 2 Profitable Stocks with Exciting Potential and 1 We Turn Down [Yahoo! Finance]Yahoo! Finance
- LeMaitre Vascular (LMAT)'s Technical Outlook is Bright After Key Golden Cross [Yahoo! Finance]Yahoo! Finance
- LeMaitre Vascular (LMAT) Is Up 16.4% After Dividend Hike And Buyback Plan – Has The Bull Case Changed? [Yahoo! Finance]Yahoo! Finance
- How The LeMaitre Vascular (LMAT) Investment Story Is Evolving With New Targets And Guidance [Yahoo! Finance]Yahoo! Finance
LMAT
Earnings
- 2/25/26 - Beat
LMAT
Sec Filings
- 3/13/26 - Form 4
- 3/13/26 - Form 4
- 3/12/26 - Form 4
- LMAT's page on the SEC website